November 2023

Anti-abortion groups are firing off a warning shot for 2024: We’re not going anywhere. Their leaders say they’re undeterred by recent election setbacks and plan to plow ahead on what they’ve done for years, including working…

If you’re wealthy, you’ll be able to afford help in your home or care in an assisted living facility or a nursing home. If you’re poor, you can turn to Medicaid for nursing homes or aides at home. But if you’re middle-class,…

Former South Carolina governor Nikki Haley portrays herself as a voice of reason in the Republican Party. “Let’s find consensus,” she said about abortion during the first GOP primary debate. “Let’s treat this like a respectful…

BURLINGTON, Vt. — “You can’t inject a horse tranquilizer and think nothing bad is gonna happen” to you, said Ty Sears, 33, a longtime drug user now in recovery. Sears was referring to xylazine, a sedative used for animal…

Choosing where to give birth typically comes down to what hospital is most convenient to your home, where your obstetrician practices and your insurance company’s provider network. Now, the Biden administration has given…

The Department of Defense relies on hundreds, if not thousands, of weapons and products such as uniforms, batteries, and microelectronics that contain PFAS, a family of chemicals linked to serious health conditions. Now, as…

Erin Kissane, a co-founder of the COVID Tracking Project, rolled up her sleeve for the Novavax covid-19 vaccine in mid-October soon after it was finally recommended in the United States. Like many people with autoimmune diseases,…

Thank you for your interest in supporting Kaiser Health News (KHN), the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of…

A new financial report released by the Social Security Administration this week shows that the scope of the agency’s overpayment problem has continued to grow. As of Oct. 1, the SSA had an uncollected balance of $23 billion in…

Medical advances are expensive. Take Wegovy, the wildly successful obesity drug that we learned last week may also reduce the risk of heart disease. If just 10 percent of Medicare beneficiaries start taking the drug, taxpayers…